Broadened therapeutic

The therapeutic armamentarium in multiple myeloma has been significantly broadened by proteasome inhibitors, highly efficient means in controlling of multiple myeloma. Despite the developments of therapeutic regimen in treatment of multiple myeloma, still the complete remission requires a novel therapeutic strategy with significant differences in outcomes.

10p vikolindagrabar 27-07-2022 8 2   Download

The development of targeted therapies has undoubtedly broadened therapeutic options for patients with colorectal cancer (CRC). The use of bevacizumab to reduce angiogenesis has been associated with improved clinical outcomes. However, an urgent need for prognostic/predictive biomarkers for anti-angiogenic therapies still exists.

12p viamsterdam 18-09-2020 15 0   Download

Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the horizon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions,whichweremedically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the first generation of protein therapeutics was produced in recombinant Escherichia coli, most recent products usemammalian cells as production hosts.Not long after the first production of recombinant proteins in E.

179p codoc_pn87 24-11-2012 59 10   Download